Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 673-684

  Otten, Ron A ^a   Ellenberger, Dennis L ^a   Adams, Debra R ^a   Fridlund, Carol A ^a   Jackson, Eddie ^b   Pieniazek, Danuta ^a   Rayfield, Mark A ^a  

^a National Center for HIV STD and TB Prevention   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS INFECTION; SEROCONVERSION; VIRUS ISOLATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HIV-2; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTES; MACACA NEMESTRINA; PHYLOGENY; POLYMERASE CHAIN REACTION; TIME FACTORS; VIRUS REPLICATION;

EID: 0032875389     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314968     Document Type: Article

References (56)

1. 1. Rayfield MA, Sullivan P, Bandea CI, et al. HIV-1 Group O virus identified for the first time in the United States, EID 1996;2(3):209-12.
2. 2. Sharp PM, Robertson DL, Gao F, Hahn BH. Origins and diversity of human immunodeficiency viruses. AIDS 1994;8(Suppl I):S27-42.
3. 3. Subbarao S, Schochetman G. Genetic variability of HIV-1. AIDS 1996; 10(Suppl. A):S13-23.
4. 4. WHO Network for HIV Isolation and Characterization. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994;10:1327-43.
5. 5. Gao F, Yue L, Robertson DL, et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68(11):7433-47.
6. 6. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral super infection. J Exp Med 1993;177:1561-6.
7. 7. Taddeo B, Federico M, Titti F, Rossi GB, Verani P. Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step. Virology 1993;194:441-52.
8. 8. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995;171:805-10.
9. 9. Janini LM, Pieniazek D, Peralta JM, et al. Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes 1996;13:69-81.
10. 10. Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, Burke DS. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses 1994;10(5):561-7.
11. 11. Rayfield MA, Downing RG, Baggs J, et al. A molecular epidemiologic survey of HIV in Uganda. AIDS 1998;12:521-7.
12. 12. Sabino EC, Diaz RS, Brigido LF, et al. Distribution of HIV-1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil. AIDS 1996;10:1579-84.
13. 13. Subbarao S, Limpakarnjanarat K, Mastro TD, et al. HIV type I in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998;14:319-27.
14. 14. Carr JK, Salminen MO, Koch C, et al. Full length sequence and mosaic structure of human immunodeficiency virus isolate from Thailand. J Virol 1996;70:5935-43.
15. 15. Gao F, Robertson DL, Morrison SG, et al. The heterosexual HIV-1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996;70:7013-29.
16. 16. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995;40(3):249-59.
17. 17. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1 [letter]. Nature 1995;374(6518):124-6.
18. 18. Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning, AIDS Res Hum Retroviruses 1995;11(11):1423-5.
19. 19. Evans LA, Moreau J, Odehouri K, et al. Simultaneous isolation of HIV-1 and HIV-2 from AIDS patient. Lancet 1988;2:1389-91.
20. 20. George JR, Ou C-Y, Parekh B, et al. Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'lvoire. Lancet 1992;340:337-9.
21. 21. Pieniazek D, Peralta JM, Ferreira JA, et al. Identification of mixed HIV-1/ HIV-2 infections in Brazil by polymerase chain reaction. AIDS 1991;5: 1293-9.
22. 22. Rayfield M, De Cock K, Heyward W, et al. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis 1988;158:1170-6.
23. 23. Fultz PN, Srinivasan A, Greene CR, Butler D, Swenson RB, McClure HM. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol 1987;61(12):4026-9.
24. 24. Locher CP. Blackbourn DJ, Barnett SW, et al. Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response. J Infect Dis 1997; 176:948-59.
25. 25. Marthas ML, Sutjipto S, Higgins J, et al. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol 1990;64:3694-700.
26. 26. Wakrim L, Le Grand R, Vaslin B, et al. Superinfection of HIV-2-pre-infected macaques after rectal exposure to a primary isolate of SIVmac251. Virology 1996;221:206-70.
27. 27. Otten RA, Brown BG, Simon M, et al. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS 1994;8:297-306.
28. 28. Velleca WM, Palmer DF, Feorino PM, et al. Procedural guide: isolation, culture, and identification of human immunodeficiency virus. Atlanta: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention 1991.
29. 29. Lairmore MD, Hofheinz DE, Letvin NL, Stoner CS, Pearlman S, Toedter GP. Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by monoclonal antibody-based antigen capture assay. AIDS Res Hum Retroviruses 1993;9:565-71.
30. 30. Lohman BL, McChesney MB, Miller CJ, et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 1994;68:7021-9.
31. 7x7 challenge. Virology 1998;242:150-60.
32. 32. Ahmed-Ansari A, Brodie AR, Fultz PN, Anderson DC, Sell KW, McClure HM. Flow microfluorometric analysis of peripheral blood mononuclear cells from non-human primates; correlation of phenotype with immune function. Am J Primatol 1989;17:107-81.
33. 33. Axberg I, Gale MJ Jr, Afar B, Clark EA. Characterization of T-cell subsets and T-cell receptor subgroups in pigtailed macaques using two-and three-color flow cytometry. J Clin Immunol 1991;11:193-204.
34. 34. Owen SM, Ellenberger D, Rayfield M, et al. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol 1998;72:5425-32.
35. 35. McClure J, Scheible M, Steele J, et al. HIV-2 macaque model for HIV infection and pathogenesis. J Med Primatol 1994;23:244.
36. 36. Ho RJ, Agy MB, Morton WR, et al. Development of a chronically catheterized maternal-fetal macaque model to study in utero mother-to-fetus HIV transmission: a preliminary report. J Med Primatol 1996;25:218-24.
37. 37. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 1992;8: 1641-52.
38. 38. Stott EJ. Anti-cell antibody in macaques Nature 1991;353:393.
39. 39. Arthur LO, Bess JW Jr, Urban RG, et al. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995, 69:3117-24.
40. 40. Haigwood NL, Zolla-Pazner S. Humoral immunity to HIV, SIV, and SIHV. AIDS 1998;12(Suppl. A):S121-32.
41. 41. Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995;345:1342-44.
42. 42. Clements JE, Montelaro RC, Zink MC, et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 1995;69: 2737-44.
43. 43. Cranage M, Whatmore AM, Sharpe SA, et al. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 1997;229:143-54.
44. 44. Daniel MD, Kirchoff F, Czajak C, Sehgal PK, Desrosiers RC. Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-41.
45. 45. Hirsch VM, Fuerst TR, Sutter G, et al. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus ankara. J Virol 1996;70:3741-52.
46. 46. Miller CJ, McChesney MB, LU X, et al. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 1997;71:1911-21.
47. 47. Putkonen P, Walther L, Zhang YJ, et al. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat Med 1995;1:914-8.
48. 48. Shibata R, Siemon C, Czajak SC, Desrosiers RC, Martin MA. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol 1997;71:8141-8.
49. 49. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70:3724-33.
50. 50. Heeney JL, Holterman L, Haaft PT, et al. Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses 1994;10(Suppl. 2):S117-21.
51. 51. Blackbourn DJ, Locher CP, Ramachandran B, et al. CD8' cells from HIV-2-infected baboons control HIV replication. AIDS 1997;11:737-46.
52. 52. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72:164-9.
53. 53. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4' T cell responses associated with control of viremia. Science 1997; 278:1447-50.
54. 54. Ahmad A, Menezes J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996;10:258-66.
55. 55. Cole KS, Rowles JL, Jagerski BA, et al. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J Virol 1997;71:5069-79.
56. 56. Janini LM, Tanuri A, Schechter M, et al. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998;177:227-31.